Mount Yale Investment Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Buy
+6,054
New +$244K ﹤0.01% 1056
2022
Q3
– Sell
-2,289
Closed -$260K – 469
2022
Q2
$260K Buy
2,289
+158
+7% +$18.1K 0.03% 386
2022
Q1
$276K Buy
2,131
+574
+37% +$82.7K 0.03% 385
2021
Q4
$281K Sell
1,557
-19
-1% -$3.3K 0.03% 390
2021
Q3
$234K Buy
1,576
+32
+2% +$4.9K 0.03% 413
2021
Q2
$234K Buy
+1,544
New +$215K 0.03% 379

Other funds holding OMCL

Mount Yale Investment Advisors's OMCL Position: Q2 2026 in Review

Mount Yale Investment Advisors opened a new position in Omnicell (OMCL) in Q2 2026: 6,054 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #1056 among its holdings. This is a return to the name: Mount Yale Investment Advisors previously reported a position in OMCL as recently as Q2 2022.

Mount Yale Investment Advisors first reported a position in OMCL in Q2 2021 and has held it in 6 quarters since. The position peaked at $281K in Q4 2021. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Mount Yale Investment Advisors held 6,054 shares of Omnicell worth $251K as of Q2 2026.
  • Omnicell was a new Mount Yale Investment Advisors position in Q2 2026.
  • Omnicell made up ﹤0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #1056 holding.
  • Mount Yale Investment Advisors first reported a position in Omnicell in Q2 2021 and has held it in 6 quarters since.
  • Mount Yale Investment Advisors's Omnicell position peaked at $281K in Q4 2021.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.